chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tuesday night February 2nd 2021 it started with a mild cough that persisted on and off throughout the night. Wednesday morning February 3rd 2021 I woke up with a hoarse voice which continued throughout the day.  The hoarse voice remains with me as of today February 4th as I am completing this form. I've gargled my throat with warm water and salt and have been drinking warm lemon and water.
Spiking blood sugar levels; This spontaneous case was reported by a consumer and describes the occurrence of HYPERGLYCAEMIA (Spiking blood sugar levels) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERGLYCAEMIA (Spiking blood sugar levels). At the time of the report, HYPERGLYCAEMIA (Spiking blood sugar levels) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products were reported.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-095403, US-MODERNATX, INC.-MOD-2021-095337 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-095403: US-MODERNATX, INC.-MOD-2021-095337:
I had vaccine still got shingles / suspected vaccination failure; got shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient was the reporter. The age at vaccination was not reported. The patient received Shingles vaccine and still got shingles. This case was considered as suspected vaccination failure as details regarding vaccination schedule, time to onset for target disease and laboratory confirmation were unknown at the time of reporting.
rash on her left arm injection site; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events rash on her left arm injection site(Injection site rash).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 9 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 010M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 13 Feb 2021, the patient experienced the event(s) rash on her left arm injection site.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), rash on her left arm injection site,  was unknown.
pt recv vax in 1996 & exp failure to seroconvert;3 titers were done all of which indicated an inadequate titer;one of the titers was done in FEB97;
5cm area of redness and swelling on left deltoid reported the evening following injection day. Doctor on call, recommended that mother give Tylenol for discomfort and ice to area. Seen the following AM. No change in treatment.
2nd dose > 42 days after 1st dose administered; Sciatic nerve pain; Pain in the hip area; Very excruciating pain; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (2nd dose > 42 days after 1st dose administered), PAIN (Very excruciating pain), SCIATICA (Sciatic nerve pain) and ARTHRALGIA (Pain in the hip area) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced PAIN (Very excruciating pain) and ARTHRALGIA (Pain in the hip area). In May 2021, the patient experienced SCIATICA (Sciatic nerve pain). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (2nd dose > 42 days after 1st dose administered). The patient was treated with GABAPENTIN at an unspecified dose and frequency. On 12-Apr-2021, PAIN (Very excruciating pain) and ARTHRALGIA (Pain in the hip area) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (2nd dose > 42 days after 1st dose administered) and SCIATICA (Sciatic nerve pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided
Chills, nausea, headache, aches within 9-12 hours of vaccination, beginning with headache and proceeding with chills, nausea, etc.
developed chills early evening; today got a Fever of 98.3; Dragging tired; feeling joints hurt; no appetite; feels like the flu; This is a spontaneous report from a Pfizer sponsored program support. A contactable female consumer (patient) reported that a female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration on an unspecified date as single for covid-19 immunisation. Medical history included felt tired before receiving vaccine. The patient's concomitant medications were not reported. She received vaccine Yesterday and felt tired before receiving vaccine. After receiving the vaccine, she experienced developed chills early evening. Today she got a fever of 98.3, dragging tired, feeling joints hurt, no appetite, feels like the flu. She concerned what if she had started to develop covid yesterday before vaccine. The patient underwent lab tests and procedures which included body temperature: 98.3 fahrenheit. The outcome of events was unknown.  Information about lot/batch number has been requested.  Follow-up (11May2021): Follow-up attempts completed. No further information expected.
c/o local inject site, urticaria, erythema, dizziness, feeling "cold", BP 120/80, resp 78 given EPI @ 3PM called 911 transported to ER;
My menstrual cycle runs like a clock.  It was not due to happen until April 8th but I got it a week early.  I am well aware of how each day goes in my cycle and the flow has been significantly off this cycle.  The only variable was my vaccination shot.  The injection site was sore, I got headaches and the site itched for days approx 48hrs after the shot.  The cycle was almost like spotting for the first 2 days when normally the first 2-3 days are heavy.  I am going on a week of the cycle and have only had 1 normal flow day yesterday when usually after 5 days the cycle is ending.  Also had this odd burning spot on my chest and back but it only would last a few seconds.
Patient received Moderna Vaccine- dose number not specified. Reaction: Angioedema Severity: High
Swollen lymph node in the underarm area of the injection arm.; painfull lymph nodes in the underarm area of the injection arm.; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via unspecified route of administration in the right arm on 27Mar2021 at 16:15 as a single dose for COVID-19 immunisation. Medical history included lupus, blood clotting disorder, rheumatoid arthritis (RA). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via unspecified route of administration in the right arm on 03Mar2021 at 16:30 as a single dose for COVID-19 immunisation. The patient previously received adalimumab (HUMIRA) on unknown date and for unspecified indication and the patient experienced drug allergy. Concomitant medication included etanercept (ENBREL) for unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021 at 08:00, the patient experienced swollen and painful lymph node in the underarm area of the injection arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive ant treatment for events. The clinical outcome of the events swollen and painful lymph node was not resolved at this time of report. No follow-up attempts are needed. No further information is expected.
Information was received from a nurse referring to unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions, concomitant medications, drug reactions and allergies were not reported. On an unknown date, the patients received unspecified number of doses of ROTATEQ lot # N026686, oral for prophylaxis following a temperature excursion (product storage error). The vaccines were exposed to a temperature of 1.4 Celsius degrees for 28 hours without previous temperature excursion. There was a call because of a data logger. No adverse events were reported.
Joint aches - since 2008. Disorientation - since 2008. Numbness (fingers/toes) - since 2007. Astigmatism - since 2008. Lack of concentration - since 2008. Difficulty recalling or remembering words - since 2008. Receiving tx since 2008. Treated for Carpal Tunnel syndrome since 2011.
Initial and follow up information has been received from a physician assistant concerning a 10 year old female patient with no concurrent conditions and medical history who on 12-JAN-2011 was vaccinated with the first dose of GARDASIL (lot #662404/0312Y) in the left arm, secondary suspected therapy included a dose of VARIVAX (lot #666817/0002Z) in the right arm. Concomitant therapy included a dose of FLUZONE, also in the right arm. On 12-JAN-2011 the patient experienced passed out and tonic clonic movements, subsequently recovered within 5-10 seconds after the episode. It was unknown if the patient sought medical attention. There did not seem to be any environmental factors involved, and patient had eaten. The physician assistant could not confirm if patient had a seizure. No treated required. No further information is available.
This is a spontaneous report from a contactable physician via sales representative. This Physician reported similar events for four patients. This is 1st of 4 reports. An adolescent (Age: 16-17) patient of an unspecified ethnicity and gender received TRUMENBA, via an unspecified route of administration on an unspecified date, at single dose for immunization. Relevant medical history and concomitant medications were not reported. The patient experienced arm pain, swelling and fever, all on an unspecified date with outcome unknown.
Vaccinations administered to pt per fathers request to update baby vaccines. Father returned this pm to state that Pts mother had child vaccinated in April this year. Pt vaccines given at current facility as follows. Rotavirus po, Prevnar 13 Pediarix, DTaP and HIB. Vaccinations given at first facility as follows Rotavirus, IVP, HIB, HepB, DTaP.
PATIENT RECEIVED FIRST DOSE OF PFIZER. AFTER APPROXIMATELY 10 MINUTES, PATIENT STARTED  SEIZURING,FOAMING AT MOUTH AND WAS VERY RIGID.  PARAMEDICS WERE CALLED IN AND HE WAS ASSESSED.  HE REPORTED THAT THIS OCCASIONALLY HAPPENS WHEN HE GETS BLOOD DRAWS. HE RECOVERED AND WAS ABLE TO GO HOME.
Sore arm, redness at site of injection, warm to touch, neck stiffness, chills, headache.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 20Apr2022 as dose 4, single (Batch/Lot number: unknown) at the age of 65 years, in right arm for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3, single (Batch/Lot number: unknown). The patient had no relevant medical history and no known allergies. Concomitant medication(s) included: ZOLOFT; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; also reported as other medication in 2 weeks. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) unknown results, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid started on 16May2022 and stopped on 20May2022. Clinical course was reported as, Rebound covid 5 days later on 24May2022. No treatment received for symptoms and patient was recovering from symptoms.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events with the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.
I had just finished my menses last week. I started again today with abdominal cramps. I am very scheduled and this is very unusual.
Starting the night of 3/24 I began experiencing whole body itchiness. The next morning, my hands were swollen and red and painful. Throughout the day it began to turn purple. I went to urgent care and they put me on prednisone.  Over the next 5 days I began getting random rashes and hives over my body. I also felt that my asthma was getting worse.
c/o itchy at injection site and itchy all over, since left the office has had HA "between eyes", palms of hands clammy, and tired. Claritin given by mom
Heart palpitations of varying frequency and intensity, beginning 5/31 and continuing to today 7/26.
No Adverse event; Patient received a dose of the 6-11 years of age monovalent Moderna COVID-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received a dose of the 6-11 years of age monovalent Moderna COVID-19 vaccine) and NO ADVERSE EVENT (No Adverse event) in an 11-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1416B) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 22-Dec-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 22-Dec-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced WRONG PRODUCT ADMINISTERED (Patient received a dose of the 6-11 years of age monovalent Moderna COVID-19 vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient received a dose of the 6-11 years of age monovalent Moderna COVID-19 vaccine) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient received a dose of the 6-11 years of age monovalent Moderna COVID-19 vaccine).    Concomitant product use was not provided by the reporter. Patient did not receive other vaccines in the four weeks prior to COVID-19 vaccine. Patient received additional booster dose. Treatment information was not provided.
low grade fever - 48 hours extreme fatigue - 48 hours left axillary swelling and pain - 5 days
Noticed unusual knot in shoulder, which developed into chronic restrictive muscle pain that makes it difficult to perform basic movements without restrictive pain.
flu-like side effect; upset stomach that would come around lunch time and dinner time; stomach ache gave him a hard time to sleep; hard time to sleep due to stomach ache; felt uncomfortable; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like side effect), ABDOMINAL DISCOMFORT (upset stomach that would come around lunch time and dinner time), ABDOMINAL PAIN UPPER (stomach ache gave him a hard time to sleep), SLEEP DISORDER (hard time to sleep due to stomach ache) and DISCOMFORT (felt uncomfortable) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like side effect), ABDOMINAL DISCOMFORT (upset stomach that would come around lunch time and dinner time), ABDOMINAL PAIN UPPER (stomach ache gave him a hard time to sleep), SLEEP DISORDER (hard time to sleep due to stomach ache) and DISCOMFORT (felt uncomfortable). The patient was treated with BISMUTH SUBSALICYLATE (PEPTOBISMOL) for Stomach ache, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (flu-like side effect), ABDOMINAL DISCOMFORT (upset stomach that would come around lunch time and dinner time), ABDOMINAL PAIN UPPER (stomach ache gave him a hard time to sleep), SLEEP DISORDER (hard time to sleep due to stomach ache) and DISCOMFORT (felt uncomfortable) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details were provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
It started with a head congestion, headache, and a sore throat. After two days of that, I went to the doctor on 11/12/2021, at Express Care, they said I had a sinus infection. They prescribed me with amoxicillin to take 1 every 12 hours. I was also prescribed a steroid.
Initial and follow-up information has been received from a certified medical assistant concerning a 21 year old female patient who on 04-JUN-2007 was vaccinated IM in the right deltoid with the second dose of GARDASIL vaccine (lot #657868/0523U). The date of the first dose of GARDASIL vaccine was not reported. It was reported that the patient flinched, jerked the arm and pulled the needle out of her arm when receiving the injection before the full dose of the vaccine was adminstered. The reported stated that "the patient received less than half of the vaccine and some ran down her arm".  No further details were provided.  At the time of this report, the outcome of the event was unknown.  Additional information has been requested. This is in follow-up to report (s) previously received on 7/6/2007. The reported stated that "the patient received less than half of the vaccine and some ran down her arm". The reporter stated that "the patient came in the following day and received the left over vaccination". The certified medical assistant reported that the patient had recovered from the event. Additional information has been requested.
Right arm pain, unable to go to school because she cannot tolerate the pain. Patient was told to take motrin with food. Apply cool compresses on injection site. If pain gets worse or last longer than a few days she is to call the office to make an appointment so she can be seen.
bowel movement changes; Aches and pains; This spontaneous case was reported by a consumer and describes the occurrence of BOWEL MOVEMENT IRREGULARITY (bowel movement changes) and MYALGIA (Aches and pains) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BOWEL MOVEMENT IRREGULARITY (bowel movement changes) and MYALGIA (Aches and pains). At the time of the report, BOWEL MOVEMENT IRREGULARITY (bowel movement changes) outcome was unknown and MYALGIA (Aches and pains) had resolved.            Treatment and concomitant list were not provided Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-109579 (Patient Link).
Received Moderna COVID 19 vaccine on 1/8 and 2/5. Side effects with body ache and fatigue for 2 days after the first dose. Sustained fever, body ache, fatigue, intermittent headache after the second dose. Symptoms have lasted for 3 weeks so far.
sore throat, fatigue, muscle aches, headache,  nausea, low fever (less than 100);  over-the-counter drugs, rest - returned to work after a negative COVID test
102 degree fever for 24 hours; upper lip swelled up 3-4X normal. After approximately 72 hours, left arm started aching badly and achiness spread to his shoulder.